Clinical trial
Radiotherapy With Immunotherapy for Systemic Effect in Myeloma (RISE-M)
NCT03634800 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Radiotherapy With Immunotherapy for Systemic Effect in Myeloma (RISE-M)
- Lead sponsor
- Weill Medical College of Cornell University
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- October 23, 2018
- Completion date
- January 16, 2020
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.